<VariationArchive VariationID="1452016" VariationName="NC_000007.13:g.(?_66103220)_(66104219_?)del" VariationType="Deletion" Accession="VCV001452016" Version="6" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-17" DateCreated="2022-03-28" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1438774" VariationID="1452016">
      <GeneList>
        <Gene Symbol="KCTD7" FullName="potassium channel tetramerization domain containing 7" GeneID="154881" HGNC_ID="HGNC:21957" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>7q11.21</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="66628881" stop="66643229" display_start="66628881" display_stop="66643229" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="66093867" stop="66108215" display_start="66093867" display_stop="66108215" Strand="+" />
          </Location>
          <OMIM>611725</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000007.13:g.(?_66103220)_(66104219_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>7q11.21</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" innerStart="66103220" innerStop="66104219" display_start="66103220" display_stop="66104219" variantLength="1000" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.13" sequenceAccession="NC_000007" sequenceVersion="13" change="g.(?_66103220)_(66104219_?)del" Assembly="GRCh37">
            <Expression>NC_000007.13:g.(?_66103220)_(66104219_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000007.13:g.(?_66103220)_(66104219_?)del AND Progressive myoclonic epilepsy type 3" Accession="RCV002035438" Version="6">
        <ClassifiedConditionList TraitSetID="219">
          <ClassifiedCondition DB="MedGen" ID="C2673257">Progressive myoclonic epilepsy type 3</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-10-12" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-10-12" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-03-28" MostRecentSubmission="2024-06-09">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">22638565</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22693283</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27742667</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="219" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5032" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS</ElementValue>
                <XRef Type="MIM" ID="611726" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CEROID LIPOFUSCINOSIS, NEURONAL, 14</ElementValue>
                <XRef Type="MIM" ID="611726" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITHOUT INTRACELLULAR INCLUSIONS</ElementValue>
                <XRef Type="Allelic variant" ID="611725.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611725.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611725.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611725.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611725.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611725.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611725.0004" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Progressive myoclonic epilepsy type 3</ElementValue>
                <XRef ID="MONDO:0012721" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">EPM 3</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CLN14</ElementValue>
                <XRef Type="MIM" ID="611726" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">EPM3</ElementValue>
                <XRef Type="MIM" ID="611726" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2167" />
                <XRef ID="2167" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="263516" DB="Orphanet" />
              <XRef ID="C2673257" DB="MedGen" />
              <XRef ID="MONDO:0012721" DB="MONDO" />
              <XRef Type="MIM" ID="611726" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4246750" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-09" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="NM_153033.4_7_Deletion (exons 3-4)|MedGen:C2673257" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002227993" DateUpdated="2024-06-09" DateCreated="2022-03-28" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22638565</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22693283</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27742667</ID>
          </Citation>
          <Comment>This variant is a gross deletion of the genomic region encompassing exon(s) 3-4 of the KCTD7 gene, which includes the termination codon. This deletion extends beyond the assayed region for this gene and therefore may encompass additional genes. While this deletion is not anticipated to lead to nonsense mediated decay, it is expected to alter mRNA translation or result in a truncated protein product. A similar copy number variant has been observed in individual(s) with opsoclonus-myoclonus ataxia-like syndrome (PMID: 22638565). This variant disrupts a region of the KCTD7 protein in which other variant(s) (p.Ile199Serfs*74, p.Phe232Leufs*41) have been determined to be pathogenic (PMID: 22693283, 27742667). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCTD7" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000007.13:g.(?_66103220)_(66104219_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C2673257" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB14505679</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4246750" TraitType="Disease" MappingType="XRef" MappingValue="C2673257" MappingRef="MedGen">
        <MedGen CUI="C2673257" Name="Progressive myoclonic epilepsy type 3" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

